M&A Update – January 9

– DCT to be acquired by Vista Equity Partners for $19.00 cash per share, 46.3% premium, $2.6 billion
– CF.to unsolicited proposal from management at $11.25 cash per share, 30.7% premium, $1.1 billion
– ALBO to be acquired by IPSEY for $42.00 cash per share + CVR of up to $10.00, 84.0% premium, $952 million
– CINC to be acquired by AZN for $26.00 cash per share + CVR of up to $10.00, 120.7% premium, $1.3 billion
– PAYA to be acquired by NVEI for $9.75 cash per share, 25.2% premium, $1.3 billion
– AMYT to be acquired by Chiesi Farmaceutici for $14.50 per ADS + CVR of up to $2.50, 107.1% premium, $1.48 billion
– NIF-U.to to be acquired by Glencore Canada for $1.42 cash per unit, 44.9% premium, $274.6 million
– VVNT / NRG filed PREM14a, closing Q1, filed HSR Dec 20
– LMST / PEBO filed S-4/a, votes Feb 23, closing Q2
– MYOV / Sumitovant Biopharma cleared HSR